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Purpose. We describe in our study a modified standard enucleation, using sclera harvested from the enucleated eye to cover the
prosthesis in order to insert a large porous implant and to reduce postoperative complication rates in a phthisis globe. Methods.
We perform initially a standard enucleation. The porous implant (Bioceramic) is then covered only partially by the patient’s sclera.
The implant is inserted in the posterior Tenon’s space with the scleral covering looking at front. All patients were followed at least
for twelve months (average followup 16 months). Results. We performed nineteen primary procedures (19 patients, 19 eyes, x M;
x F) and secondary, to fill the orbital cavity in patients already operated by standard evisceration (7 patients, 7 eyes). There were no
cases of implant extrusion. The orbital volume was well reintegrated. Conclusion. Our procedure was safe and eﬀective. All patients
had a good cosmetic result after final prosthetic fitting and we also achieved good prothesis mobility.
1. Introduction
After enucleation and evisceration, the socket loss becomes
another potential problem. Placement of an orbital implant
can provide good cosmesis and proper motility.
Porous orbital implants have been popular in recent
years, because they own several advantages over traditional
alloplastic implants.
The relatively light weight of porous implants may reduce
pressure over the lower lids, decreasing the likelihood of low-
er eyelid sag and sulcus deformity [1].
Porous implants also permit the placement of a peg for
direct coupling to a prosthesis, allowing better prosthesis
motility, and supporting the weight of the prosthesis to re-
duce the risk of developing lower lid laxity with long-term
prosthetic wear [2].
Less implant migration and extrusion are found because
of better fibrovascular ingrowth of microporous structure [1,
2].
Numerous microporous orbital implants have been used
to replace orbital volume including glass, ivory, coralline hy-
droxyapatite (HA) (Bio-Eye) [3], the porous polyethylene
(Medpor) [4], and the aluminium oxide (Bioceramic) [5].
Risk factors for early dehiscence include previous surgery
or trauma, radiotherapy, and secondary implantation [6].
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Figure 1: Phases of surgical preparation of the phthisis globe. (a) Enucleation of phthisis bulbous. A traction suture is placed on the cornea.
(b) The sclera covers only the anterior surface of the porous implant; a mesh Vicryl suture maintains the sclera in a fixed position. (c) The
sclera is longitudinally marked in blue color. (d) The posterior Tenon’s fascia is dissected to receive the prothesis.
When an orbital implant becomes exposed, it is often nec-
essary to resort to further surgery [7].
Autogenous fascia, cadaveric sclera or fascia, bovine
pericardium, or synthetic material such as polyglactin mesh
have been used to cover an exposed hydroxyapatite orbital
implant [7–10].
One of the drawbacks with a traditional evisceration is
that there is a limit to the size of the implant that can be
placed within the scleral cavity. With a standard evisceration,
it is usually not possible to place anything larger than a
16mm sphere [11]. Several modifications to the procedure
have been reported to enable the placement of larger
implants within the scleral cavity. Most of these techniques
include cutting the sclera anteroposteriorly with or without
separating the optic nerve from the scleral flaps [12–14].
We conducted a prospective interventional study assess-
ing the eﬃcacy of an alternative surgical technique that
combine evisceration with enucleation procedure in order to
insert a larger porous implant in a phthisis globe.
2. Materials and Methods
This study was conducted at the Eye Clinic of the University
of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy and
it was approved by the local Ethical Committee and adhered
to the tenets of the Declaration of Helsinki.
26 consecutive patients who underwent surgery between
January 2009 and December 2010 were enrolled in the study,
19 for a primary evisceration and 7 for secondary implanta-
tion.
The type of procedure and the implant used, the char-
acteristics, and benefits of operation were explained to the
patients and a written consent was obtained.
All patients signed informed consent forms for surgery.
Surgeries were performed by one expert surgeon (G. L.
Zigiotti).
Patients were all seen at 1 and 3 weeks and 3, 6, 12
months postoperatively by the medical staﬀ. An assessment
was made of the socket in all cases. Comment was passed on
the conjunctival wound and implant motility, and the pres-
ence of conjunctival dehiscence was recorded.
2.1. Surgical Technique. Since a traction suture was placed
on the cornea, a 360-degree limbal peritomy was made. In
order to secure the four rectus muscles, a suture was inserted
at the end of each of them while the superior and inferior
oblique muscles were cut oﬀ. A standard enucleation was
performed and the optic nerve was transected (Figure 1(a)).
The globe was prepared to receive the bioceramic implant
using an accessory surgical table. The cornea and the
intraocular uveal tissues contents were removed by means
of an evisceration spoon. The corneal hole was enlarged by
bilateral Z incisions in order to insert a 22mm or 20mm
bioceramic prothesis. The sclera was placed in an antibiotic
solution for five minutes.
The 5-0 Vicryl single suture mesh implant was inserted
and the sclera was sutured (Figure 1(b)). The posterior part
of the sclera was marked by a surgical pen (Figure 1(c)). The
hole corresponding to the optic nerve entrance was enlarged
using a finger (Figure 1(d)), and the implant, partially
covered by the sclera, was inserted behind the posterior
Tenon’s fascia (Figure 2(a)), with the posterior scleral pole
facing anteriorly (Figure 2(b)). Sutures were performed in
three layers. The first layer was a continuous suture of the
posterior Tenon’s fascia with the four rectus muscles sutured
on it (Figure 2(c)). The second layer was the suture of the
anterior Tenon’s fascia performed with interrupted stitches.
The third layer was the conjunctiva closed with a continuous
suture. If necessary interrupted sutures might be placed on it
to secure the implants (Figure 2(d)).
3. Results
We enrolled 19 eyes of 19 patients, 9 males, 10 females (mean
age 55.4 ± 9.7 years), for a primary evisceration, and 7 pa-
tients, 2 males, 5 females, 7 eyes (mean age 60.2 ± 7.6 years),
for secondary implantation in superior sulcus eye deformity.
3.1. Primary Procedure. All eyes enrolled in the study did
not show visual residual function. We performed surgery for
the following reasons: 10 eyes were aﬀected by bulbar
phthisis and pain; 5 eyes had corneal perforation and endo-
phthalmitis with no bulbar phthisis; 2 eyes had bulbar
phthisis after multiple surgical procedures for glaucoma
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Figure 2: Insertion of the bioceramic prothesis. (a) The partially
covered implant is inserted. (b) The marked pole is in front. (c) The
four rectus muscles are sutured on the posterior Tenon’s fascia. (d)
The conjunctival layer of the suture is finished.
surgery; 2 eyes had leukocoria with a normal bulbus for an
aesthetic reason. In those 19 eyes there were inserted 4 im-
plants of 20mm of diameter and 15 implants of 22mm of
diameter.
We had no postoperative infection and all patients fitted
and external prothesis.
3.2. Secondary Procedure. All eyes were previously eviscer-
ated with the insertion of an implant. One patient underwent
secondary procedure for the extrusion of a previously im-
planted silastic implant of 14mm of diameter; it was inserted
a 22mm bioceramic implant. In the other 6 cases, our pro-
cedure was performed to increase the orbital cavity volume
in order to reduce superior sulcus deformity. The implant
diameter changed from 12 to 20 in one case; from 14 to 22 in
two cases; from 16 to 22 in two cases; from 18 to 22 in one
case.
All patients were followed at least for twelve months
(average followup 16.6 months). All patients fitted an
external prothesis in the operated eye. We did not find
complications, such as implant infection, implant exposure,
socket discomfort, or conjunctival thinning.
4. Conclusion
Many authors consider evisceration to be a procedure that
allows better movement than enucleation [15, 16].
To prevent socket volume loss, superior sulcus depres-
sion, and secondary eyelid malposition, it is necessary to
place an orbital implant within the sclera with a volume of
4mL to 5mL (20–22mm implant) [17].
Unfortunately, most patients who undergo an eviscer-
ation do not have scleral dimension to accommodate an
implant larger than 16mm [11].
This is the reason why the cornea is sometimes retained.
Unfortunately, a whitish cornea can be unpleasant to look at
and it may cause pain. The use of a small implant does not
allow complete fullness of the orbital cavity and the result
is an inadequate sustain of the external prothesis. It means
that the target of better eye movement with evisceration, in
the majority of cases, is not achieved due to an insuﬃcient
orbital volume filling.
In our study we showed that it is possible to partially
cover porous orbital implant, such as aluminium oxide
(Bioceramic), with the patient’s sclera. Our procedure starts
by performing an enucleation. Once the implant is inserted
in the orbital cavity the scleral tissue is put in front of it.
Therefore, we obtained a good healing plane for the posterior
and anterior Tenon’s fascia and conjunctiva. Our procedure
allows satisfactory movement of the external prothesis be-
cause the four rectus muscles are sutured to the posterior
Tenon’s fascia and because with this technique the orbital
volume is completely filled. Currently, we do not consider
the insertion of a peg system in any patient.
In this study, our procedure was safe and eﬀective, with
no cases of extrusion, migration, or infection. All patients
had a good cosmetic result after final prosthetic fitting.
The bioceramic implant is a safe and eﬀective treatment
for blind painful eye. Eyes undergoing evisceration with
implantation of this implant achieve good motility and a
good cosmetic result.
The position of the implant behind the posterior Tenon’s
fascia allows a good cicatrisation of the covering tissues,
because this posterior Tenon’s fascia has never been operated
on. Our procedure might be a good alternative especially in
case of ocular phthisis, but larger cohort study group are
needed.
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